Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer
在三阴性乳腺癌小鼠模型中,navitoclax 和 venetoclax 与阿霉素联合用药的疗效存在差异
期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2026.1661424
As Sobeai, Homood M; Alanazi, Abdulrahman M; Alotaibi, Faisal; Alhoshani, Ali; Alhazzani, Khalid; Almutairi, Mashal M; Almudimeegh, Sultan; Al-Ramadi, Basel K; Chakraborty, Eesha; Saleh, Tareq; Gewirtz, David A; Harada, Hisashi; Alotaibi, Moureq R